Last10K.com

Fluoropharma Medical, Inc. (FPMI) SEC Filing 8-K Material Event for the period ending Wednesday, June 22, 2022

Fluoropharma Medical, Inc.

HISTORY TOOLS
CIK: 1402785 Ticker: FPMI

View differences made from one to another to evaluate Fluoropharma Medical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Fluoropharma Medical, Inc..

Continue

Assess how Fluoropharma Medical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Fluoropharma Medical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Fluoropharma Medical, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: FPMI
CIK: 1402785
Form Type: 8-K Corporate News
Accession Number: 0001903596-22-000393
Submitted to the SEC: Wed Jun 22 2022 8:23:58 PM EST
Accepted by the SEC: Thu Jun 23 2022
Period: Wednesday, June 22, 2022
Industry: In Vitro And In Vivo Diagnostic Substances
Events:
  1. Change in Control
  2. Event for Officers
  3. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/fpmi/0001903596-22-000393.htm